Literature DB >> 7957663

Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.

F Capony1, T Braulke, C Rougeot, S Roux, P Montcourrier, H Rochefort.   

Abstract

The secretion of pro-cathepsin D (pro-cath-D) in some human metastatic breast cancer cells (MCF7, MDA/MB231), contrary to normal mammary cells, is not increased by ammonium chloride treatment, indicating a mannose-6-phosphate-independent sorting to lysosomes. By studying a variety of cell lines and lysosomal enzymes, we show that secretion of newly synthesized pro-cath-D was not mediated by the 46-kDa mannose-6-phosphate receptor (MPR) and that its resistance to NH4Cl for secretion was specific to cath-D and not to other lysosomal enzymes. This resistance appeared to be correlated with the basal hypersecretion of pro-cath-D, but not with its overexpression. By contrast, pro-cath-D secretion was increased by NH4Cl in fibroblasts and nontumoral epithelial mammary cells, suggesting a specificity for cancer cells. Immunofluorescence staining showed that pro-cath-D, but neither cathepsin B nor beta-hexosaminidase, accumulated in intracytoplasmic vesicles of cells treated with ammonium chloride. In pulse--chase experiments and by subcellular fractionation on Percoll gradient, cath-D was found to be sorted into dense lysosomes whether cells were treated or not by NH4Cl. Treatment of cells with NH4Cl, however, inhibited processing and maturation of pro-cath-D, which was also observed in light vesicles in the absence of NH4Cl. Part of pro-cath-D, but not processed enzyme, was also found to be membrane associated in saponin-permeabilized cells. We conclude that in breast cancer cells, the MPR-independent pathway of pro-cath-D to lysosome is predominant compared to normal cells and other lysosomal enzymes. This alternative pathway should therefore be considered, in addition to MPR, to explain pro-cath-D sorting and activation in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957663     DOI: 10.1006/excr.1994.1327

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Cathepsin D: Regulation in mammary gland remodeling, misregulation in breast cancer.

Authors:  Evette S Radisky
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

2.  Effect of carbohydrate position on lysosomal transport of procathepsin L.

Authors:  R G Lingeman; D S Joy; M A Sherman; S E Kane
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

3.  Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.

Authors:  Valérie Laurent-Matha; Danielle Derocq; Christine Prébois; Nobuhiko Katunuma; Emmanuelle Liaudet-Coopman
Journal:  J Biochem       Date:  2006-03       Impact factor: 3.387

4.  Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.

Authors:  D Couissi; V Dubois; C Remacle; E Schonne; A Trouet
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

5.  Procathepsin D and cancer: From molecular biology to clinical applications.

Authors:  Vaclav Vetvicka; Aruna Vashishta; Sujata Saraswat-Ohri; Jana Vetvickova
Journal:  World J Clin Oncol       Date:  2010-11-10

6.  Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.

Authors:  D Derocq; C Prébois; M Beaujouin; V Laurent-Matha; S Pattingre; G K Smith; E Liaudet-Coopman
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

7.  Loss of melanoregulin (MREG) enhances cathepsin-D secretion by the retinal pigment epithelium.

Authors:  Laura S Frost; Vanda S Lopes; Frank P Stefano; Alvina Bragin; David S Williams; Claire H Mitchell; Kathleen Boesze-Battaglia
Journal:  Vis Neurosci       Date:  2013-04-23       Impact factor: 3.241

8.  A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells.

Authors:  Sanna Partanen; Stephan Storch; Hans-Gerhard Löffler; Andrej Hasilik; Jaana Tyynelä; Thomas Braulke
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

9.  Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology.

Authors:  Samikshan Dutta; Sohini Roy; Navatha S Polavaram; Marissa J Stanton; Heyu Zhang; Tanvi Bhola; Pia Hönscheid; Terrence M Donohue; Hamid Band; Surinder K Batra; Michael H Muders; Kaustubh Datta
Journal:  Cancer Res       Date:  2015-11-11       Impact factor: 12.701

Review 10.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.